There is no specific treatment for retinitis pigmentosa. Retinitis pigmentosa is a dystrophic degenerative lesion of the photoreceptor cells and pigment epithelium in the fundus of the eye and is a hereditary eye disease. The disease usually develops in both eyes, usually in children or adolescents, worsens in adolescence, and leads to severe visual impairment and blindness in middle age or old age due to macular involvement of the fundus. It is a common blinding eye disease worldwide, and there is a lack of effective treatment. Most treatments for retinitis pigmentosa are currently under research, including stem cell transplantation, gene therapy, and research on retinal prostheses. Stem cell therapy is a new treatment method that applies healthy stem cells to replace degenerated retinal cells to promote cell regeneration and create new intercellular connections to improve visual function. Gene therapy is also theoretically therapeutic, but is currently limited to animal trials. In summary, retinitis pigmentosa is a genetic eye disease for which there is no effective treatment. For people with low vision, they can try wearing visual aids to improve their reading ability. Research on gene therapy, retinal stem cell transplantation, and retinal prostheses offer hope for patients to brighten their lives.